Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Multi Cohort Study of Tazemetostat in Combination With Various Treatments For R/R Hematologic Malignancies - Drug Trials For Money - Paid Clinical Trials

Multi Cohort Study of Tazemetostat in Combination With Various Treatments For R/R Hematologic Malignancies

Multi Cohort Study of Tazemetostat in Combination With Various Treatments For R/R Hematologic Malignancies
Condition:   Relapsed/Refractory
Interventions:   Drug: Tafasitamab;   Drug: Lenalidomide;   Drug: Tazemetostat;   Drug: Acalabrutinib;   Drug: Daratumumab;   Drug: Hyaluronidase-Fihj;   Drug: Pomalidomide 4 MG;   Drug: Dexamethasone 20mg;   Drug: Dexamethasone 40mg
Sponsor:   Epizyme, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 26, 2022 / by / in
Comments